Protein expression, crystallization and in-silico studies on cytochrome P450 Oxidoreductase wildtype and mutant variants

被引:0
作者
Shafqat, Naeem [1 ]
Amdani, Siti Nornadhirah [1 ]
Ming, Long Chiau [1 ,2 ]
机构
[1] Univ Brunei Darussalam, PAPRSB Inst Hlth Sci, Gadong, Brunei
[2] Sunway Univ, Sch Med & Life Sci, Sunway City, Selangor, Malaysia
来源
JOURNAL OF RESEARCH IN PHARMACY | 2024年 / 28卷 / 02期
关键词
Cytochrome P450 oxidoreductase (POR); cytochrome P450 oxidoreductase deficiency (PORD); POR protein expression; POR crystallization; POR mutants; ANTLEY-BIXLER-SYNDROME; CONGENITAL ADRENAL-HYPERPLASIA; COMPOUND HETEROZYGOUS MUTATIONS; P450; OXIDOREDUCTASE; IMPAIRED STEROIDOGENESIS; AMBIGUOUS GENITALIA; IDENTIFICATION; DEFICIENCY; PHENOTYPE; DELETION;
D O I
10.29228/jrp.718
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
: Cytochrome P450 oxidoreductase (POR) is a crucial membrane-bound enzyme that facilitates the transfer of electrons to all cytochrome P450 (CYP450) enzymes. Several mutations in the POR gene have been reported to cause cytochrome P450 oxidoreductase deficiency (PORD), an autosomal recessive genetic disorder. This study explored the consequences of seven POR missense mutations (Y181D, A287P, R457H, R498P, C569Y, Y607C, and H628P), which have been documented in PORD patients, on the structural integrity and stability of the POR enzyme in vitro . The comparison between these mutants and the wild-type POR focused on in vitro protein expression, purification, and crystallization characteristics. The mutation-induced alterations in the POR architecture significantly influenced the protein's expression and crystallization capabilities. The magnitude of these effects on the enzyme's behavior varied from moderate to severe, contingent on the mutation's nature and position. This research illuminates the influence of specific mutations on POR stability, underlining the necessity of understanding mutation -driven effects on enzyme stability to devise personalized therapeutic approaches for PORD patients. Future studies will involve the functional characterization of these mutant enzymes to further understand their impact on the POR enzyme's activity and stability
引用
收藏
页码:560 / 570
页数:11
相关论文
共 42 条
[1]   Compound Heterozygous Mutations Affect Protein Folding and Function in Patients With Congenital Sucrase-Isomaltase Deficiency [J].
Alfalah, Marwan ;
Keiser, Markus ;
Leeb, Tosso ;
Zimmer, Klaus-Peter ;
Naim, Hassan Y. .
GASTROENTEROLOGY, 2009, 136 (03) :883-892
[2]   Congenital adrenal hyperplasia caused by mutant P450 oxidoreductase and human androgen synthesis: analytical study [J].
Arlt, W ;
Walker, EA ;
Draper, N ;
Ivison, HE ;
Ride, JP ;
Hammer, F ;
Chalder, SM ;
Borucka-Mankiewicz, M ;
Hauffa, BP ;
Malunowicz, EM ;
Stewart, PM ;
Shackleton, CHL .
LANCET, 2004, 363 (9427) :2128-2135
[3]   Antley-Bixler Syndrome: Surgical Management of Ambiguous Genitalia - A Case Report [J].
Boia, E. S. ;
Popoiu, M. C. ;
Puiu, M. ;
Stanciulescu, C. M. ;
David, V. L. .
MEDICAL PRINCIPLES AND PRACTICE, 2014, 23 (04) :384-386
[4]   Long-term follow-up of a female with congenital adrenal hyperplasia due to P450-oxidoreductase deficiency [J].
Bonamichi, Beatriz D. S. F. ;
Santiago, Stella L. M. ;
Bertola, Debora R. ;
Kim, Chong A. ;
Alonso, Nivaldo ;
Mendonca, Berenice B. ;
Bachega, Tania A. S. S. ;
Gomes, Larissa G. .
ARCHIVES OF ENDOCRINOLOGY METABOLISM, 2016, 60 (05) :500-504
[5]  
But W. M., 2010, Hong Kong Medical Journal, V16, P59
[6]   Mutant P450 oxidoreductase causes disordered steroidogenesis with and without Antley-Bixler syndrome [J].
Flück, CE ;
Tajima, T ;
Pandey, AV ;
Arlt, W ;
Okuhara, K ;
Verge, CF ;
Jabs, EW ;
Mendonça, BB ;
Fujieda, K ;
Miller, WL .
NATURE GENETICS, 2004, 36 (03) :228-230
[7]   Impact on CYP19A1 activity by mutations in NADPH cytochrome P450 oxidoreductase [J].
Fluck, Christa E. ;
Pandey, Amit V. .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2017, 165 :64-70
[8]   Deletion of P399_E401 in NADPH cytochrome P450 oxidoreductase results in partial mixed oxidase deficiency [J].
Flueck, Christa E. ;
Mallet, Delphine ;
Hofer, Gaby ;
Samara-Boustani, Dinane ;
Leger, Juliane ;
Polak, Michel ;
Morel, Yves ;
Pandey, Amit V. .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2011, 412 (04) :572-577
[9]  
Flück CE, 2011, ENDOCR DEV, V20, P63, DOI 10.1159/000321221
[10]   Cytochrome P450 oxidoreductase gene mutations and Antley-Bixler syndrome with abnormal genitalia and/or impaired steroidogenesis: Molecular and clinical studies in 10 patients [J].
Fukami, M ;
Horikawa, R ;
Nagai, T ;
Tanaka, T ;
Naiki, Y ;
Sato, N ;
Okuyama, T ;
Nakai, H ;
Soneda, S ;
Tachibana, K ;
Matsuo, N ;
Sato, S ;
Homma, K ;
Nishimura, G ;
Hasegawa, T ;
Ogata, T .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (01) :414-426